United Therapeutics | UTHR - Interest Income

Stock Price
478.27
Daily Change
3.27 0.69%
Monthly
-2.33%
Yearly
35.32%
Q1 Forecast
455.03

United Therapeutics reported $51.3M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Amarin USD 3.37M 3.37M Dec/2024
Baxter International USD 14M 3M Jun/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 50M 4M Jun/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.12 0.17 Sep/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025